Vemurafenib | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Vemurafenib

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers, 1 FDA Orange Book, 5 Europe, 1 Canada, 2 Australia, 1 South Africa

RELATED EXCIPIENT COMPANIES

2 DKSH, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 Corel Pharma Chem, 1 DFE Pharma, 3 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 3 Kerry, 1 Novo Excipients, 1 Pluviaendo, 1 Prachin Chemical, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Sigachi Industries, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Coating Systems & Additives, 10 Disintegrants & Superdisintegrants, 5 Controlled & Modified Release, 4 Film Formers & Plasticizers, 3 Lubricants & Glidants, 2 Topical, 2 Granulation, 2 Fillers, Diluents & Binders, 2 Coloring Agents, 2 Parenteral, 1 Direct Compression, 1 Rheology Modifiers, 1 Taste Masking, 1 API Stability Enhancers

DIGITAL CONTENT

47 NEWS #PharmaBuzz

47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 2 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 1 US Exclusivities, 3 Health Canada Patents

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1HOFFMANN LA ROCHE

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

HOFFMANN LA ROCHE

PharmScience R&D

Not Confirmed

Contact us
to update this info